Drug Type Small molecule drug |
Synonyms HSK 31679, HSK-31679, HSK31679 |
Target |
Mechanism THR-β agonists(Thyroid hormone receptor beta-1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
MASH | Phase 2 | CN | 23 Nov 2023 | |
Hypercholesterolemia | Phase 2 | CN | 26 Apr 2023 | |
MAFLD | Phase 2 | CN | 26 Apr 2023 | |
Primary hypercholesterolemia | Phase 2 | CN | 21 Mar 2023 |